Novo Nordisk A/S (NYSE:NVO) is one of the 781 companies in the GICS Health Care sector, and a component of the 134 company Pharmaceuticals GICS industry group within this sector. The market value of NVO is $102.5 billion which places it in the top 10% of its industry group. The stock's current Portfolio Grader score places it 4 among the 134 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 46 among the 781 companies in the sector, and number 257 in the nearly 5,000 company Portfolio Grader universe. More
Why Wynn Resorts, Limited Is a Better Buy Than Activision Blizzard, Inc. Stock
These are two seemingly different companies in different industries. ATVI stock has a P/E almost identical to WYNN. Which is the better buy? More
Buy Micron Technology, Inc. Stock on this Dip, But Don’t Hold It Forever
The good times won't last forever for MU, but they will persist long enough to power MU stock to above $50. More
Poor Industry Group Rank Drops Motif Bio (MTFB) to Hold
Motif Bio Plc (NULL:MTFB) is one of 134 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 781 company GICS Health Care sector. MTFB's market value is $110.2 billion which falls in the top decile in its industry group. The ranking for MTFB by Portfolio Grader places it 48 among the 134 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 292 among the 781 companies in the sector, and number 1,762 in the nearly 5,000 company Portfolio Grader universe. More
Snap Inc Stock Cannot Be Saved by an App Redesign
Will the Snapchat redesign work? Possibly. Is SNAP stock a good buy? Absolutely not - expectations for Snapchat stock remain too high. More
